Masoud H. Manjili

9.1k total citations
124 papers, 4.7k citations indexed

About

Masoud H. Manjili is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Masoud H. Manjili has authored 124 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Immunology, 56 papers in Oncology and 36 papers in Molecular Biology. Recurrent topics in Masoud H. Manjili's work include Immunotherapy and Immune Responses (53 papers), Immune Cell Function and Interaction (37 papers) and Cancer Immunotherapy and Biomarkers (33 papers). Masoud H. Manjili is often cited by papers focused on Immunotherapy and Immune Responses (53 papers), Immune Cell Function and Interaction (37 papers) and Cancer Immunotherapy and Biomarkers (33 papers). Masoud H. Manjili collaborates with scholars based in United States, Iraq and China. Masoud H. Manjili's co-authors include Maciej Kmieciak, Harry D. Bear, John R. Subjeck, Xiang‐Yang Wang, Laura Graham, Keith L. Knutson, Johanna K. Morales, Kyle K. Payne, Chunqing Guo and Paul B. Fisher and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Masoud H. Manjili

119 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masoud H. Manjili United States 35 2.6k 2.2k 1.7k 561 354 124 4.7k
Phillip Wong United States 31 3.2k 1.2× 1.3k 0.6× 1.5k 0.8× 555 1.0× 513 1.4× 91 5.4k
Mikael C. I. Karlsson Sweden 39 3.4k 1.3× 1.1k 0.5× 1.9k 1.1× 593 1.1× 295 0.8× 104 5.4k
Anna Mondino Italy 39 3.8k 1.4× 1.9k 0.9× 2.2k 1.3× 469 0.8× 349 1.0× 109 6.6k
Masahisa Jinushi Japan 35 3.9k 1.5× 2.1k 1.0× 1.4k 0.8× 418 0.7× 573 1.6× 72 5.6k
Takuya Osada United States 42 2.1k 0.8× 2.0k 0.9× 2.7k 1.6× 1.1k 1.9× 291 0.8× 117 5.5k
Santiago Zelenay United Kingdom 27 5.1k 2.0× 2.1k 1.0× 1.4k 0.8× 414 0.7× 354 1.0× 38 6.7k
Weihua Xiao China 36 2.4k 0.9× 1.7k 0.8× 1.3k 0.7× 489 0.9× 251 0.7× 82 3.9k
Cai Zhang China 44 2.6k 1.0× 1.2k 0.5× 1.7k 1.0× 738 1.3× 795 2.2× 144 4.9k
Mads Hald Andersen Denmark 43 4.7k 1.8× 3.4k 1.6× 2.6k 1.5× 346 0.6× 288 0.8× 206 7.1k
Tahseen H. Nasti United States 25 2.6k 1.0× 2.6k 1.2× 877 0.5× 311 0.6× 275 0.8× 58 4.4k

Countries citing papers authored by Masoud H. Manjili

Since Specialization
Citations

This map shows the geographic impact of Masoud H. Manjili's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masoud H. Manjili with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masoud H. Manjili more than expected).

Fields of papers citing papers by Masoud H. Manjili

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masoud H. Manjili. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masoud H. Manjili. The network helps show where Masoud H. Manjili may publish in the future.

Co-authorship network of co-authors of Masoud H. Manjili

This figure shows the co-authorship network connecting the top 25 collaborators of Masoud H. Manjili. A scholar is included among the top collaborators of Masoud H. Manjili based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masoud H. Manjili. Masoud H. Manjili is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Manjili, Masoud H., et al.. (2023). From Reductionistic Approach to Systems Immunology Approach for the Understanding of Tumor Microenvironment. International Journal of Molecular Sciences. 24(15). 12086–12086.
2.
Liu, Zheng, Chunqing Guo, Swadesh K. Das, et al.. (2021). Engineering T Cells to Express Tumoricidal MDA-7/IL24 Enhances Cancer Immunotherapy. Cancer Research. 81(9). 2429–2441. 12 indexed citations
3.
Jahanban‐Esfahlan, Rana, Khaled Seidi, Masoud H. Manjili, et al.. (2019). Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer. Cancers. 11(8). 1207–1207. 86 indexed citations
4.
Manjili, Masoud H.. (2017). Tumor Dormancy and Relapse: From a Natural Byproduct of Evolution to a Disease State. Cancer Research. 77(10). 2564–2569. 90 indexed citations
5.
Toor, Amir A., et al.. (2016). On the organization of human T-cell receptor loci: log-periodic distribution of T-cell receptor gene segments. Journal of The Royal Society Interface. 13(114). 20150911–20150911. 4 indexed citations
6.
Sulek, Jay, et al.. (2016). The Expression of Cancer/Testis Antigens in Kidney and Bladder Malignancies. 8(2). 1 indexed citations
7.
Ascierto, Maria Libera, Michael O. Idowu, Yingdong Zhao, et al.. (2013). Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients. Journal of Translational Medicine. 11(1). 145–145. 81 indexed citations
8.
Payne, Kyle K., Christine K. Zoon, Wen Wan, et al.. (2013). Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells. Breast Cancer Research and Treatment. 142(1). 45–57. 20 indexed citations
9.
Saleem, Sheinei, Rebecca Martin, Johanna K. Morales, et al.. (2012). Cutting Edge: Mast Cells Critically Augment Myeloid-Derived Suppressor Cell Activity. The Journal of Immunology. 189(2). 511–515. 72 indexed citations
10.
Kmieciak, Maciej, Roy Sabo, Catherine Roberts, et al.. (2012). Distinct Oligoclonal T Cells Are Associated With Graft Versus Host Disease After Stem-Cell Transplantation. Transplantation. 93(9). 949–957. 17 indexed citations
11.
Zhang, Qifang, Jamie Sturgill, Maciej Kmieciak, et al.. (2011). The Role of Tyk2 in Regulation of Breast Cancer Growth. Journal of Interferon & Cytokine Research. 31(9). 671–677. 13 indexed citations
12.
Kmieciak, Maciej, Kyle K. Payne, Michael O. Idowu, et al.. (2011). Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure. Journal of Translational Medicine. 9(1). 35–35. 18 indexed citations
13.
Santisteban, Marta, Jennifer M. Reiman, Michael K. Asiedu, et al.. (2009). Immune-Induced Epithelial to Mesenchymal Transition In vivo Generates Breast Cancer Stem Cells. Cancer Research. 69(7). 2887–2895. 320 indexed citations
14.
Worschech, Andrea, Maciej Kmieciak, Keith L. Knutson, et al.. (2008). Signatures Associated with Rejection or Recurrence in HER-2/ neu –Positive Mammary Tumors. Cancer Research. 68(7). 2436–2446. 32 indexed citations
15.
Morales, Johanna K., Maciej Kmieciak, Laura Graham, et al.. (2008). Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells. Cancer Immunology Immunotherapy. 58(6). 941–953. 49 indexed citations
16.
Kmieciak, Maciej, Keith L. Knutson, Catherine I. Dumur, & Masoud H. Manjili. (2007). HER‐2/neu antigen loss and relapse of mammary carcinoma are actively induced by T cell‐mediated anti‐tumor immune responses. European Journal of Immunology. 37(3). 675–685. 77 indexed citations
17.
Reiman, Jennifer M., Maciej Kmieciak, Masoud H. Manjili, & Keith L. Knutson. (2007). Tumor immunoediting and immunosculpting pathways to cancer progression. Seminars in Cancer Biology. 17(4). 275–287. 145 indexed citations
18.
Manjili, Masoud H., Xiangyang Wang, Xing Chen, et al.. (2003). HSP110-HER2/ neu Chaperone Complex Vaccine Induces Protective Immunity Against Spontaneous Mammary Tumors in HER-2/ neu Transgenic Mice. The Journal of Immunology. 171(8). 4054–4061. 85 indexed citations
19.
Manjili, Masoud H., Robert Henderson, Xiangyang Wang, et al.. (2002). Development of a recombinant HSP110-HER-2/neu vaccine using the chaperoning properties of HSP110.. PubMed. 62(6). 1737–42. 75 indexed citations
20.
Assmar, Mehdi, et al.. (1999). Immunogenicity of Gamma-Irradiated Toxoplasma gondii Tachyzoites in Mice. 3(3). 93–97. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Phillip Wong Breakdown of academic impact, for papers by Mikael C. I. Karlsson Breakdown of academic impact, for papers by Anna Mondino Breakdown of academic impact, for papers by Masahisa Jinushi Breakdown of academic impact, for papers by Takuya Osada Breakdown of academic impact, for papers by Santiago Zelenay Breakdown of academic impact, for papers by Weihua Xiao Breakdown of academic impact, for papers by Cai Zhang Breakdown of academic impact, for papers by Mads Hald Andersen Breakdown of academic impact, for papers by Tahseen H. Nasti
Rankless by CCL
2026